Studies on protein-liposome coupling using novel thiol-reactive coupling lipids: Influence of spacer length and polarity

被引:34
作者
Fleiner, M [1 ]
Benzinger, P [1 ]
Fichert, T [1 ]
Massing, U [1 ]
机构
[1] Dept Clin Res, Tumor Biol Ctr, D-79106 Freiburg, Germany
关键词
D O I
10.1021/bc000101m
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To optimize the preparation of immunoliposomes, we investigated the coupling of thiolated IgG and BSA to liposomes using a novel group of coupling lipids. All lipids consist of cholesterol as membrane anchor and a thiol-reactive maleimide headgroup, linked by a spacer that differs in length and polarity (ethylene glycol, tetraethylene glycol, PEG 400, PEG 1000, dodecyl). In addition, lipids differ in the electrophilicity of the maleimide group (p- or m-maleimidobenzoic ester). In the case of BSA, coupling efficiency strongly depended on the electrophilicity of the maleimide group as well as on the spacer polarity: The less electrophilic meta constitution seems to be an advantage over the p-maleimidobenzoic ester, resulting in higher coupling efficiency. Polar spacers (tetraethylene glycol, 46%) achieved a higher coupling efficiency than a nonpolar spacer with approximately the same length (dodecyl, 15%).When liposomes containing coupling lipids with the spacers tetraethylene glycol, PEG 400, and PEG 1000 were linked to BSA, coupling efficiencies were in a medium range and similar (41-46%) but were lower for the short ethylene glycol spacer (30%). In contrast, for IgG coupling efficiencies correlated with increasing spacer length. Pest results were obtained using coupling lipids with a long polar spacer (PEG 1000) (65%), whereas a coupling lipid bearing a short spacer (ethylene glycol) resulted in a low coupling efficiency of 12%.
引用
收藏
页码:470 / 475
页数:6
相关论文
共 38 条
[1]  
Allen Theresa M., 1994, Journal of Liposome Research, V4, P1, DOI 10.3109/08982109409037027
[2]   A NEW STRATEGY FOR ATTACHMENT OF ANTIBODIES TO STERICALLY STABILIZED LIPOSOMES RESULTING IN EFFICIENT TARGETING TO CANCER-CELLS [J].
ALLEN, TM ;
BRANDEIS, E ;
HANSEN, CB ;
KAO, GY ;
ZALIPSKY, S .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1237 (02) :99-108
[3]   LIPOSOMES CONTAINING SYNTHETIC LIPID DERIVATIVES OF POLY(ETHYLENE GLYCOL) SHOW PROLONGED CIRCULATION HALF-LIVES INVIVO [J].
ALLEN, TM ;
HANSEN, C ;
MARTIN, F ;
REDEMANN, C ;
YAUYOUNG, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1066 (01) :29-36
[4]   Targeting of endothelial KDR receptors with 3G2 immunoliposomes in vitro [J].
Benzinger, P ;
Martiny-Baron, G ;
Reusch, P ;
Siemeister, G ;
Kley, JT ;
Marmé, D ;
Unger, C ;
Massing, U .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2000, 1466 (1-2) :71-78
[5]   MOLECULAR MECHANISM OF THE LIPID VESICLE LONGEVITY INVIVO [J].
BLUME, G ;
CEVC, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1146 (02) :157-168
[6]   Immunogenicity of new heterobifunctional cross-linking reagents used in the conjugation of synthetic peptides to liposomes [J].
Boeckler, C ;
Frisch, B ;
Muller, S ;
Schuber, F .
JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 191 (01) :1-10
[7]   RECENT ADVANCES IN LIPOSOMAL DRUG-DELIVERY SYSTEMS [J].
CHONN, A ;
CULLIS, PR .
CURRENT OPINION IN BIOTECHNOLOGY, 1995, 6 (06) :698-708
[8]   Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs [J].
Crosasso, P ;
Brusa, P ;
Dosio, F ;
Arpicco, S ;
Pacchioni, D ;
Schuber, F ;
Cattel, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (07) :832-839
[9]  
de Menezes DEL, 1998, CANCER RES, V58, P3320
[10]   A NEW REAGENT WHICH MAY BE USED TO INTRODUCE SULFHYDRYL-GROUPS INTO PROTEINS, AND ITS USE IN THE PREPARATION OF CONJUGATES FOR IMMUNOASSAY [J].
DUNCAN, RJS ;
WESTON, PD ;
WRIGGLESWORTH, R .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :68-73